Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 13.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 2000 to 2009

Recipients with Heart-Lung Transplants

  Year of Transplant
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Functioning Graft at Discharge 33 21 22 17 35 29 24 29 21 24
With Immunosuppression Info 33 21 22 17 35 29 24 28 20 24
Corticosteroids Any in Category 100.0% 100.0% 100.0% 94.1% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Steroids 100.0% 100.0% 100.0% 94.1% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Cyclosporine Any in Category 81.8% 71.4% 59.1% 47.1% 37.1% 48.3% 29.2% 3.6% 10.0% 16.7%
Cyclosporin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 5.0% 4.2%
Sandimmmune 6.1% 9.5% 13.6% 5.9% 0.0% 0.0% 0.0% 0.0% 0.0% 4.2%
Neoral 72.7% 57.1% 40.9% 23.5% 22.9% 31.0% 12.5% 3.6% 5.0% 0.0%
Gengraf 3.0% 4.8% 4.5% 17.6% 14.3% 13.8% 16.7% 0.0% 0.0% 8.3%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 3.4% 0.0% 0.0% 0.0% 0.0%
Tacrolimus Any in Category 27.3% 23.8% 45.5% 52.9% 65.7% 55.2% 75.0% 96.4% 90.0% 91.7%
Tacrolimus 27.3% 23.8% 45.5% 52.9% 65.7% 55.2% 75.0% 96.4% 90.0% 87.5%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4.2%
Antimetabolites Any in Category 93.9% 95.2% 95.5% 82.4% 82.9% 96.6% 91.7% 85.7% 95.0% 91.7%
Mycophenolate Mofetil 45.5% 52.4% 40.9% 29.4% 54.3% 55.2% 70.8% 67.9% 85.0% 75.0%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.6% 5.0% 0.0%
Azathioprine 48.5% 42.9% 54.5% 52.9% 28.6% 41.4% 20.8% 14.3% 5.0% 16.7%
mTOR Inhibitors Any in Category 0.0% 0.0% 0.0% 5.9% 2.9% 0.0% 0.0% 0.0% 0.0% 0.0%
Sirolimus 0.0% 0.0% 0.0% 5.9% 2.9% 0.0% 0.0% 0.0% 0.0% 0.0%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of October 1, 2010.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.